Thank you for sharing these research articles. I wish oncology teams would integrate cardiologists who specialize in cancer to make it easier for patients to monitor their heart health during and after cancer treatment. My cardiologist defers to my oncologist with his recommendations but I'm not always confident that as much as I trust my oncologist, she is able to stay abreast of all cardiac issues.

As someone who developed atrial fib shortly before my breast cancer diagnosis and who is taking Kisqali with its known cardiac issues, I probably would prefer someone who is on the aggressive side of monitoring. To me that would mean continuing to monitor with EKGS and Echos even beyond what Kisqali guidelines suggest. But that's just me. I would prefer to be on top of any cardiotoxic effects before they become acute.